Wednesday, October 1, 2014

Cut into the dialysis business! Friends of the Chinese drug cooperation agreement signed with the A


Race-based Celgene Corporation executives should be invited to visit Taiwan Ministry of Economic Affairs 2013/03/01 Wangwei Zu / writer Celgene Corporation, francis crick race-based executives should francis crick be invited to visit Taiwan's Ministry of Economic Affairs, and National Taiwan University Hospital, Ministry francis crick of Economic Affairs, the Department of Health and other units to start visiting exchange, expect to have further cooperation. After the race-based Celgene also ECFA by the Ministry of Economy to foreign francis crick visit 12 major pharmaceutical manufacturers in the sole. Race-based American francis crick Corporation executive vice chairman Mark J. Alles said, focusing on the Asian market as the world's biopharmaceutical industry's most prominent areas in which Taiwan's francis crick booming basis and clinical progress, but as Europe into Asia's Best partners. The Ministry of Economic Affairs francis crick should be invited to Taiwan to participate in the "2013 Economic Department francis crick biotech drug research platform forum", he was very happy to share their experience on behalf francis crick of race-based company in the field of biopharmaceutical development, race-based company for two new drugs - treatment of multiple myeloma Revlimid, and the treatment of adverse treatment of myeloproliferative syndrome Vidaza, francis crick respectively, to obtain reimbursement at 101 in December and 102 in February, race-based company for the future development of these two products in Taiwan's deep heavyweight confidence. Race-based high-level visit to Taiwan to visit the most important travel is to visit a national research center of excellence in clinical trials francis crick and National Taiwan University Hospital (NCTRC). Mark said that he understood a number of multinational pharmaceutical companies to cooperate with the National Taiwan University Hospital, the establishment of clinical research and development francis crick center, and National Taiwan University Hospital for their clinical treatment of liver cancer including cancer, stomach cancer, lung cancer and other exchange views, these race-based company is also therapeutic areas of concern direction and hope for the future, including National Taiwan University Hospital or other biopharmaceutical industry can have a variety of opportunities for cooperation. Mark pointed out, Celgene race-based pharmaceutical companies in the United States was established in 1986, is a biopharmaceutical company committed to the development and research and development of innovative drugs, the main areas include leukemia drugs, anti-inflammatory factor drugs, and stem cell therapy treatments, the annual investment R & D expenses among the best in the industry. He said that in addition to its own research and development of new therapeutic drugs, Celgene is also actively acquisition-related pharmaceutical companies, to expand francis crick coverage more disease areas, including the acquisition of Pharmion Corporation in 2008, into a poor treatment of myeloproliferative syndrome drug Vidaza, and In 2010 M & Glouster company, into the treatment of epidermal T-cell lymphoma and peripheral T-cell lymphoma drug Istodax, and in the same year the company Abraxis francis crick acquisitions, into the treatment of breast cancer, lung cancer, pancreatic cancer drug -Abraxane, and Abraxane by the use of innovative nano drug albumin embedding technique (nab platform, nanoparticle albumin francis crick bound), the race-based company from leukemia therapeutic areas to the areas of formal treatment of solid cancers. Mark stressed that in order to strengthen Celgene's product line, there are still nine human clinical trials ongoing one to three new products, the future is expected to apply in the 16 disease indications. As to whether there are plans to increase its investment francis crick in Taiwan biomedical industry, or the establishment of the Asia-Pacific region Celgene plans R & D center in Taiwan. Mark said, Celgene for Taiwan and other Asia-Pacific countries have a holistic plan considerations, visit to Taiwan, Taiwan's biomedical industry to have a more detailed understanding of the experience of visiting Taiwanese let Celgene layout helps biopharmaceutical market great future is bound to have an opportunity for cooperation. francis crick Founded in August 2008 the race-based Limited is a subsidiary of American race-based Celgene Corporation in Taiwan, there are currently listed on the main drug treatment of multiple myeloma (MM, multiple myeloma) drug Revlimid (Switzerland complex beauty capsules, science called lenalidomide), and the treatment of bone marrow dysplasia syndrome (MDS, myelodysplastic syndromes) drug Vidaza (Commission Danza injections, scientific name azacitidine), respectively, in June 2010 and in March the Department of Health to obtain drug licenses, 2012 December, January 2013 to obtain reimbursement. The future will be listed other leukemia treatments, updated treatment of multiple myeloma drugs, and drug therapy solid tumors (eg breast francis crick cancer, francis crick lung cancer, pancreatic cancer, etc.). Speaking Celgene's global distribution plan, Mark said, Celgen francis crick to actively expand business territory, 2003 to set up its European headquarters in Switzerland, have set up subsidiaries in European countries in 2008 will reach out to the Asian countries, the establishment of regional headquarters, bringing Celgene to the status of the global biopharmaceutical companies. 2012, Celgene Corporation ranked Fortune (Fortune Magazine) Fortune 500 companies, as the international fast-growing biopharmaceutical francis crick companies.
Xie Jin River: Find new faces 2014-08-29 12:03 Taiwan stock bulls in the electronic newspaper "first exploration investment Week" on 1793. Text / Xie Jin River "to explore investment Week" on 1793 a few days ago, a long-lost contact southern francis crick elders suddenly called to ask me the stock, francis crick he began to ask me Ding Hao Can buy? I asked him, "how do you know ho Ding ...
Free Nokia Terms aborted drug stocks rebounded new shackles francis crick industry, academics hide responsibility to expose the general discussion over months Replies mechanism September 27, 2014 [GAO Jia Jing, Chen Yingxin Taipei francis crick "Nokia terms" thunder, little rain, due to targeted too, the industry rebounded, scholars do not want to bear weighed charges, the competent authorities in order to "set francis crick the terms for specific industries, not showing the truth ...
Dalin sea shareholder backing, Jane Feng Ren shares at 04:11 on September 17, 2014 Duhui Rong Xing upcoming francis crick Login Liansheng medicine cabinet in the 19th, in addition to 王长怡, Wang Ruiyu two famous women, francis crick in fact, the management team and shareholder backing is not small, heavy sea-level celebrities Lin, UMC chairman of Hong Jiacong and Forepi founder Jane Feng Ren also have to participate a coffee, let Liansheng drug did not ...
Where to find the way out to see how Taiwan's biotechnology development? francis crick After Nokia event, let us wake up to the biotech francis crick drug development is not only time consuming, but also a high-risk business, of course, is also a high profit! Investors before investing in biotechnology should look at how to stop listening to? Wen. Chen Yiting photography. Zheng Wei Qi two years hottest emerging industries, non-biotech industry must go! She is the star of the government touted the industry, in 2008 the legislature passed "...
Ding Hao Zhang Nianci: Nice edge and do something! Taiwan card to create new drugs Tycoon Network reporter Zhang Xuhong 2014-09-28 12:20 Taiwan Taipei Ding Hao, chairman Zhang Nianci (in) the creation of Ding Hao very exciting story, francis crick he said, everyone should francis crick bear good margin, good things will naturally be honored appear, Taiwan francis crick biotech is taking francis crick off, we must build a Taiwan brand new drugs, let the world ...
Cancer drug pairs combine accident become a trend at 15:03 on June 19 2014 CNA experts pointed out that, combined with anti-CTLA-4 antibody and anti-PD-1 antibody in combination therapy in patients with refractory cancer has proven to extend life, "This is the future trend, francis crick but also have great potentials. " The first session of the Don Award "biopharmaceutical Award" winner, by American scholar James. Allison (J ...
Cut into the dialysis business! Friends of the Chinese drug cooperation agreement signed with the American Friends of China biotech medicine (4120) announced that it will with the American Medinox biotechnology company, signed a cooperation and development of new drugs NOX-100 sales contracts, the cooperation agreement, the Friends of the Chinese drug made in Taiwan China, the exclusive right to sell South Korea, Australia, New Zealand and Southeast Asia and other countries; while Medinox owns the line ...
Lai biomedical focus light cord blood stem cells in the adult first domestic bank this rich family safety net correspondent Chen-Yu / report 2014-04-10 francis crick Lai Biomedical light cord blood bank since the merger in 2009 the well-known "blessing biotechnology," and the whole cord blood stem cells After the storage business, has become one of the country's largest francis crick stem cell storage francis crick and professional services company, nearly two years on both sides of the surrounding skin care products business francis crick dedicated to the promotion, even ...
Biotech stocks rose a lot of money to turn the National Development Fund [United Daily News reporter Lin on Jo / Taipei 2014.07.13 04:25 am Yu Chang case once again become a topic, the company's share price has become a "vindication" indicators, in fact, in recent years, students Technology shares favorite investment biotech companies, including the National Development Fund, have earned a lot of money, NDC officials, the fund biotech stocks, listed cabinet section includes ...
2014 (991) September (120) 29/09 (10) 27/09 (31) 21/09 (9) 17/09 (10) 12/09 (24) 06/09 ( 7) 03/09 (8) 01/09 (21)

No comments:

Post a Comment